Interleukin-33-mediated signaling pathway

pathway activity — cross-omics
GO:0038172Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Interleukin-33-mediated signaling pathway pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are ARHGAP25, IL33, and LAT_S224, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Interleukin-33-mediated signaling pathway activity versus ARHGAP25 in GBM (Pearson r = 0.40).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMARHGAP25 →+0.508+0.081<.001.00337
LSCCIL33 →+0.631+0.093<.001<.00136
LUADLAT_S224 →+0.761+0.076<.001<.00136
LUADMAIP1 →-0.306-0.063<.001<.00136
LSCCARHGDIB →+0.401+0.074<.001<.00136
LSCCAFG3L2 →-0.477-0.077<.001.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0038172 vs ARHGAP25 — GBM

Per-sample scatter of Interleukin-33-mediated signaling pathway activity vs ARHGAP25 in GBM.

Explore this scatter interactively →

Exploration